Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
US7687644B2 · kind B2 · utility
8Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2005 |
| Grant date | Mar 30, 2010 |
| Priority date | — |
| Expiry date | Aug 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.